PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders
Bogna Grygiel-Górniak,1 Iwona Ziółkowska-Suchanek,2 Elżbieta Kaczmarek,3 Maria Mosor,2 Jerzy Nowak,2 Mariusz Puszczewicz1 1Department of Rheumatology and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland; 2Institute of Human Genetics, Polish Academy of S...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-03-01
|
| Series: | Clinical Interventions in Aging |
| Subjects: | |
| Online Access: | https://www.dovepress.com/ppargamma-2-and-adrb3-polymorphisms-in-connective-tissue-diseases-and--peer-reviewed-article-CIA |
| _version_ | 1818424509913366528 |
|---|---|
| author | Grygiel-Górniak B Ziółkowska-Suchanek I Kaczmarek E Mosor M Nowak J Puszczewicz M |
| author_facet | Grygiel-Górniak B Ziółkowska-Suchanek I Kaczmarek E Mosor M Nowak J Puszczewicz M |
| author_sort | Grygiel-Górniak B |
| collection | DOAJ |
| description | Bogna Grygiel-Górniak,1 Iwona Ziółkowska-Suchanek,2 Elżbieta Kaczmarek,3 Maria Mosor,2 Jerzy Nowak,2 Mariusz Puszczewicz1 1Department of Rheumatology and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland; 2Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland; 3Department of Bioinformatics and Computational Biology, Poznan University of Medical Sciences, Poznan, Poland Background: The aim of the research genetic study was to investigate the association between variants (C1431T and Pro12Ala) of the peroxisome proliferator-activated receptor (PPARgamma-2) gene, Trp64Arg polymorphism of the beta-3-adrenergic receptor gene and lipid profile in Polish population including group of 103 patients with connective tissue disease (CTD) and 103 sex- and age-matched controls in context of statin use. Methods: Anthropometric and biochemical parameters were measured by routine methods, followed by genotyping (TagMan® Genotyping Assays, PCR-restriction fragment length polymorphism analysis). Nearly 30% of CTD patients used statins and 10% of the control group. Results: Although there were no differences between alleles and genotypes prevalence between CTD vs control groups, interesting lipid-gene associations were noted in this study. A higher level of triglycerides (TAG) and TAG/high-density lipoprotein (HDL) ratios was observed in CTD patients compared to controls. Similar differences were noted in CTD and control groups without statin treatment. Atherogenic markers: the atherogenic index of plasma, TAG/HDL and low-density lipoprotein/HDL ratio were low in the analyzed groups. Of the six analyzed polymorphisms, the Pro12Pro or C14131C or Trp64Trp genotypes were related to higher TAG and TAG/HDL ratios in patients with CTD; however, the highest TAG values were observed in the presence of the Trp64Trp genotype. Conclusion: Lipid disorders were present in both groups independent of statin treatment (mixed dyslipidemia and hypercholesterolemia were observed in the CTD and control groups, respectively). The risk of dyslipidemia increases with age. The presence of Pro12Pro, C14131C and Trp64Trp genotypes is related to higher TAG level in CTDs, and of these the Trp64Trp variant most reliably predicts hypertriglyceridemia. Keywords: C1431T, Pro12Ala, Trp64Arg polymorphisms, lipoproteins, rheumatic diseases, statins |
| first_indexed | 2024-12-14T13:59:11Z |
| format | Article |
| id | doaj.art-0ba8c927bcd841f682a0d088aac7d66c |
| institution | Directory Open Access Journal |
| issn | 1178-1998 |
| language | English |
| last_indexed | 2024-12-14T13:59:11Z |
| publishDate | 2018-03-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical Interventions in Aging |
| spelling | doaj.art-0ba8c927bcd841f682a0d088aac7d66c2022-12-21T22:58:45ZengDove Medical PressClinical Interventions in Aging1178-19982018-03-01Volume 1346347237375PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disordersGrygiel-Górniak BZiółkowska-Suchanek IKaczmarek EMosor MNowak JPuszczewicz MBogna Grygiel-Górniak,1 Iwona Ziółkowska-Suchanek,2 Elżbieta Kaczmarek,3 Maria Mosor,2 Jerzy Nowak,2 Mariusz Puszczewicz1 1Department of Rheumatology and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland; 2Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland; 3Department of Bioinformatics and Computational Biology, Poznan University of Medical Sciences, Poznan, Poland Background: The aim of the research genetic study was to investigate the association between variants (C1431T and Pro12Ala) of the peroxisome proliferator-activated receptor (PPARgamma-2) gene, Trp64Arg polymorphism of the beta-3-adrenergic receptor gene and lipid profile in Polish population including group of 103 patients with connective tissue disease (CTD) and 103 sex- and age-matched controls in context of statin use. Methods: Anthropometric and biochemical parameters were measured by routine methods, followed by genotyping (TagMan® Genotyping Assays, PCR-restriction fragment length polymorphism analysis). Nearly 30% of CTD patients used statins and 10% of the control group. Results: Although there were no differences between alleles and genotypes prevalence between CTD vs control groups, interesting lipid-gene associations were noted in this study. A higher level of triglycerides (TAG) and TAG/high-density lipoprotein (HDL) ratios was observed in CTD patients compared to controls. Similar differences were noted in CTD and control groups without statin treatment. Atherogenic markers: the atherogenic index of plasma, TAG/HDL and low-density lipoprotein/HDL ratio were low in the analyzed groups. Of the six analyzed polymorphisms, the Pro12Pro or C14131C or Trp64Trp genotypes were related to higher TAG and TAG/HDL ratios in patients with CTD; however, the highest TAG values were observed in the presence of the Trp64Trp genotype. Conclusion: Lipid disorders were present in both groups independent of statin treatment (mixed dyslipidemia and hypercholesterolemia were observed in the CTD and control groups, respectively). The risk of dyslipidemia increases with age. The presence of Pro12Pro, C14131C and Trp64Trp genotypes is related to higher TAG level in CTDs, and of these the Trp64Trp variant most reliably predicts hypertriglyceridemia. Keywords: C1431T, Pro12Ala, Trp64Arg polymorphisms, lipoproteins, rheumatic diseases, statinshttps://www.dovepress.com/ppargamma-2-and-adrb3-polymorphisms-in-connective-tissue-diseases-and--peer-reviewed-article-CIAC1431TPro12AlaTrp64Arg polymorphismslipoproteinsrheumatic diseasesstatins |
| spellingShingle | Grygiel-Górniak B Ziółkowska-Suchanek I Kaczmarek E Mosor M Nowak J Puszczewicz M PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders Clinical Interventions in Aging C1431T Pro12Ala Trp64Arg polymorphisms lipoproteins rheumatic diseases statins |
| title | PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders |
| title_full | PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders |
| title_fullStr | PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders |
| title_full_unstemmed | PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders |
| title_short | PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders |
| title_sort | ppargamma 2 and adrb3 polymorphisms in connective tissue diseases and lipid disorders |
| topic | C1431T Pro12Ala Trp64Arg polymorphisms lipoproteins rheumatic diseases statins |
| url | https://www.dovepress.com/ppargamma-2-and-adrb3-polymorphisms-in-connective-tissue-diseases-and--peer-reviewed-article-CIA |
| work_keys_str_mv | AT grygielgorniakb ppargamma2andadrb3polymorphismsinconnectivetissuediseasesandlipiddisorders AT ziołkowskasuchaneki ppargamma2andadrb3polymorphismsinconnectivetissuediseasesandlipiddisorders AT kaczmareke ppargamma2andadrb3polymorphismsinconnectivetissuediseasesandlipiddisorders AT mosorm ppargamma2andadrb3polymorphismsinconnectivetissuediseasesandlipiddisorders AT nowakj ppargamma2andadrb3polymorphismsinconnectivetissuediseasesandlipiddisorders AT puszczewiczm ppargamma2andadrb3polymorphismsinconnectivetissuediseasesandlipiddisorders |